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Letter to Editor
 
To the EditorTo the Editor
Needs-Based Health-Related Quality of Life Measurement: 
New Wine in Old Bottles?
 
To the Editor—Several recent articles, including
those appearing in this 
 
Value in Health
 
 supplement
(
 
Value in Health
 
 2004; 7(S1)), advocate the adop-
tion of a needs-based approach to the measurement
of quality of life (QoL). Because this advocacy seems
to in part be driven by the perceived failures of other
models, it might be useful to consider its advantages
over its rivals. In one sense, the needs-based
approach has already demonstrated a technical
superiority of sorts as many, perhaps most; measures
of QoL lack an explicit, formal model at all. But,
ﬁrst things ﬁrst. What exactly is a needs-based
model (NBM)? There may be a better formulation of
its components and distinguishing characteristics
elsewhere, but for the purposes of this commentary
we might use a recent article that adopted this model
and apply forensic analysis to deduce this informa-
tion. The term “quality of life” is applicable here,
although in the context of the treatment of ill-health
and disease the term “health-related quality of life”
is more accurate and is to be preferred. The model
argues that disease-related impairment and disa-
bility inﬂuence a person’s ability to meet his or her
needs  and  that  QoL  [1]  is  deﬁned  as  the  extent
to which needs are fulﬁlled. QoL assessment is
intended to provide an accurate summary of the
impact of disease from the perspective of the patient.
It is important to note that it is not intended to deter-
mine disease severity or to aid in deciding on the
most appropriate intervention for individual
patients. The model is particularly useful … (in)
allowing impacts to be summarized in a single out-
come measure. The concepts underpinning NBM
thus appear to be the following:
1. Impairment and disability inﬂuence capacity to
meet “needs”;
2. Quality of life measures the extent to “needs”
are met—thereby revealing the gap between
expectation and reality;
3. Patient perception constitutes the authoritative
view in deﬁning that gap.
Need here appears to be exclusively deﬁned in
terms of patient perception. Nevertheless, need is
capable of deﬁnition in terms of multiple and
(potentially conﬂicting) interpretations. Is “need”
really more than the identiﬁcation of an attribute, a
function, a good, a service or product that is neces-
sary in some way, but is otherwise lacking? Is it
more adequately deﬁned as simply the capacity to
derive beneﬁt? Should “need(s)” be described in
terms of Maslow’s hierarchy? Beyond this, can we
distinguish “needs” with higher status or rank from
others of a lower order? It is this latter process that
introduces the concept of preference where some
needs dominate others. The difference between
“needs” and “wants” is an important one too, as
can be witnessed whenever a jackpot prize is
announced in the UK National Lottery. Many peo-
ple express the “want”—few, if any, have a real
“need” for the prize.
Suppose for a moment that we have a shared
understanding of what is meant by the concept of
“needs”; an important next question relates to the
means by which that concept is translated into a
descriptive system and more importantly, by whom.
The NBM approach dictates that we consult exclu-
sively with patients in deriving candidate items.
This is described as a basic requirement of QoL
instruments because it ensures that the content of
the ﬁnal instrument is relevant to the target popu-
lation and that issues considered important by
patients are not omitted. The method adopted for
this journey of discovery is that of unstructured
qualitative interviews with patients. This is akin to
the artist who works with so-called found objects—
the rusted can or bicycle wheel has signiﬁcance
ascribed to them by the artist, even though the cas-
ual bystander still perceives them as the junk that
they are in terms of their own reality. So it is with
the transcribed dialogue derived from such unstruc-
tured interviews. The found objects of conversation
form the basis for a post hoc reconstruction, albeit
one that is based in part on the rigor of content
analysis. The research scientist necessarily has to
impose a certain discipline on the otherwise chaotic
mass of evidence with which they are confronted. In
so doing, they bring to bear their own value judg-
ments about how to restructure and present those
data in a form that makes them more readily avail-
able to third parties. Hence, although the source of
materials used in the construction of measures of
QoL might very well be patients or others with rel-
evant ﬁrst-hand knowledge of ill health, those pri-
mary data are overlaid by the research methodology
that is applied to them and the research analysts
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who utilize those methods. It becomes difﬁcult to
know how this resulting hybrid can be described as
exclusively representing the patients’ views.
This position can be exacerbated in subsequent
item testing and selection. The choices made to
include, or exclude, items are in effect the exercise
of values held by the researcher about what is, or is
not important or relevant—whether or not that
choice is based on technical grounds arising from,
say, the use of Rasch models or IRT methods in gen-
eral. Rasch models are essentially probabilistic in
character nature and rest on the assumed ordering
of items on an underlying QoL continuum and the
extent to which individuals reﬂect their own QoL
through their responses to those items. This is in
itself a perfectly sustainable approach to modeling
QoL, but we should be clear about how that prob-
abilistic model operates. Items that meet the
requirements perform satisfactorily “count.” Those
that fail “do not count.” Nevertheless, it is perfectly
feasible to take account of patient preferences in the
course of item reduction. In so doing a new set of
problems emerge. Individual patients will have indi-
vidual preferences as to what is important for them.
How is the instrument developer to aggregate these
data across the patient group as a whole without
recourse to some method or other that attenuates
the contribution of the individual? Does NBM rep-
resent patients’ views or patient’s views? Once those
patient preferences are set aside by the researcher
then that characteristic becomes redundant and a
claim for the superiority of NBM is correspondingly
diminished.
Where such models are used to weight items then
any suggestion of proximity to patients in terms of
importance and relevance becomes virtually impos-
sible to sustain. Poorly performing items can never-
theless reﬂect aspects of QoL that are highly value
by patients. Nevertheless, once the technical process
of item reduction has kicked in there is no escaping
the analytic steamroller. Furthermore, much of the
process of testing reliability and performance in the
ﬁnished product relies on, for example, discriminat-
ing between patients with known characteristics,
for example disease severity, or convergence with
other data generated by other QoL instruments.
Whether or not those tests should be expected to
help in establishing performance takes us back to a
crucial issue that precedes the use of any single
approach, NBM or otherwise.
In designing any new QoL instrument we need to
be clear about the purpose for which it is intended.
If as suggested earlier, QoL measurement is
intended merely as a way of summarizing the
patient’s perspective of their illness, then this is to
deny its wider potential. If, however, we are seeking
to measure QoL to determine health outcomes and
where we wish to ensure that those outcomes are
expressed in terms that are recognized as valuable
by patients, then there is undoubted merit in ensur-
ing that the instrument captures those aspects of the
condition and/or its treatment that they value. It is
this attribute of value that separates QoL measure-
ment in general from more narrowly focused clini-
cal or condition-speciﬁc measures. Where the values
embedded in a measure arise from the researcher or
the methods they choose to employ, in place of the
patient then that differentiating factor is lost and
with that loss goes any claim for conceptual supe-
riority. The needs-based approach is neither new
nor novel. It is simply the repackaging of ideas and
techniques that have formed part and parcel of
much instrument development over the past three
decades. It remains benign so long as instrument
developers and users do not elevate it to orthodoxy.
The danger for the untutored is that needs-based
becomes needs-must.—Paul Kind, MPhil, Principal
Investigator, Outcomes Research Group, Center for
Health Economics, Alcuin College, University of
York, and Editorial Advisory Board member of
Value in Health.
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